XTNT (Xtant Medical Holdings) Cyclically Adjusted FCF per Share: $-2.74 (As of Mar. 2026)


XTNT Xtant Medical Holdings Inc XTNT
27 GF Score
Price $0.41
GF Value $0.62
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Xtant Medical Holdings Cyclically Adjusted FCF per Share?

Xtant Medical Holdings XTNT -1.69% 27 Cyclically Adjusted FCF per Share is $-2.74 as of Mar. 2026. GuruFocus rates XTNT with a GF Score™ of 27/100 and a GF Value™ of $0.62 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Xtant Medical Holdings's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.016. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-2.74 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 28.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Xtant Medical Holdings was 28.10% per year. The lowest was 14.50% per year. And the median was 21.65% per year.

As of today (2026-07-05), Xtant Medical Holdings's current stock price is $0.4129. Xtant Medical Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-2.74. Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF of today is .


Xtant Medical Holdings  (AMEX:XTNT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Xtant Medical Holdings Cyclically Adjusted FCF per Share Related Terms


Xtant Medical Holdings Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Xtant Medical Holdings's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xtant Medical Holdings Cyclically Adjusted FCF per Share Chart

Xtant Medical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.28 -7.86 -6.39 0.00 -2.92

Xtant Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.40 -4.01 -3.26 -2.92 -2.74

XTNT vs POSC, LUNG, MDAI: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Cyclically Adjusted Price-to-FCF falls into.


XTNT
27GF Score
Xtant Medical Holdings Inc XTNT
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xtant Medical Holdings Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Xtant Medical Holdings's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.016/330.2130*330.2130
=-0.016

Current CPI (Mar. 2026) = 330.2130.

Xtant Medical Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -10.265 241.018 -14.064
201609 -4.533 241.428 -6.200
201612 -2.858 241.432 -3.909
201703 0.084 243.801 0.114
201706 -1.284 244.955 -1.731
201709 -0.538 246.819 -0.720
201712 0.302 246.524 0.405
201803 0.014 249.554 0.019
201806 -0.004 251.989 -0.005
201809 -0.086 252.439 -0.112
201812 0.126 251.233 0.166
201903 0.027 254.202 0.035
201906 0.029 256.143 0.037
201909 -0.112 256.759 -0.144
201912 -0.041 256.974 -0.053
202003 -0.155 258.115 -0.198
202006 -0.015 257.797 -0.019
202009 -0.023 260.280 -0.029
202012 0.004 260.474 0.005
202103 -0.023 264.877 -0.029
202106 0.020 271.696 0.024
202109 -0.015 274.310 -0.018
202112 -0.002 278.802 -0.002
202203 -0.017 287.504 -0.020
202206 -0.004 296.311 -0.004
202209 -0.028 296.808 -0.031
202212 -0.025 296.797 -0.028
202303 -0.025 301.836 -0.027
202306 -0.027 305.109 -0.029
202309 -0.030 307.789 -0.032
202312 -0.009 306.746 -0.010
202403 -0.050 312.332 -0.053
202406 -0.043 314.175 -0.045
202409 -0.028 315.301 -0.029
202412 0.000 315.605 0.000
202503 0.001 319.799 0.001
202506 0.006 322.561 0.006
202509 0.028 324.800 0.028
202512 0.033 324.054 0.034
202603 -0.016 330.213 -0.016

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-2.74 mean?
Xtant Medical Holdings (XTNT) has a Cyclically Adjusted FCF per Share of $-2.74 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Xtant Medical Holdings and its competitors.
Is Xtant Medical Holdings' Cyclically Adjusted FCF per Share too high?
Xtant Medical Holdings' current Cyclically Adjusted FCF per Share is $-2.74. Overall, Xtant Medical Holdings has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Xtant Medical Holdings' Cyclically Adjusted FCF per Share compare to POSC and LUNG?
Xtant Medical Holdings' Cyclically Adjusted FCF per Share of $-2.74 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Xtant Medical Holdings and its competitors. Xtant Medical Holdings's current Cyclically Adjusted FCF per Share is $-2.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xtant Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, Xtant Medical Holdings (XTNT) is currently considered Possible Value Trap. The stock's GF Value™ is $0.62, compared to a current price of $0.41 — trading 33.4% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $-2.74. Xtant Medical Holdings' overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Xtant Medical Holdings (XTNT), the current Cyclically Adjusted FCF per Share is $-2.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xtant Medical Holdings (XTNT) Overvalued in 2026?

Based on GuruFocus' analysis, Xtant Medical Holdings stock appears to be undervalued. The current stock price of $0.41 is trading 33.4% below its estimated GF Value™ of $0.62. GuruFocus considers Xtant Medical Holdings to be Possible Value Trap.

Key valuation signals for XTNT:

  • Cyclically Adjusted FCF per Share: $-2.74
  • GF Value™: $0.62 vs. price of $0.41 (33.4% below fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the XTNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Xtant Medical Holdings Business Description

Address 664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
27GF Score

Get the complete analysis for XTNT

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.41
Price
$0.62
GF Value